3-formylrifamycin sv has been researched along with isoniazid in 2 studies
| Studies (3-formylrifamycin sv) | Trials (3-formylrifamycin sv) | Recent Studies (post-2010) (3-formylrifamycin sv) | Studies (isoniazid) | Trials (isoniazid) | Recent Studies (post-2010) (isoniazid) |
|---|---|---|---|---|---|
| 8 | 1 | 3 | 21,815 | 960 | 4,493 |
| Protein | Taxonomy | 3-formylrifamycin sv (IC50) | isoniazid (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 4.85 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 8.29 | |
| Putative FAD-containing monooxygenase MymA | Mycobacterium tuberculosis H37Rv | 4.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eichelbaum, M; Jensen, JC; Loos, U; Mikus, G; Musch, E; Schwabe, HK | 1 |
| Kotecha, JS; Rathod, IS; Savale, SS; Shah, PB; Shah, SA; Shishoo, CJ | 1 |
1 trial(s) available for 3-formylrifamycin sv and isoniazid
| Article | Year |
|---|---|
Pharmacokinetics of oral and intravenous rifampicin during chronic administration.
Topics: Administration, Oral; Adolescent; Adult; Aged; Biological Availability; Drug Therapy, Combination; Ethambutol; Female; Humans; Infusions, Parenteral; Isoniazid; Male; Metabolic Clearance Rate; Middle Aged; Rifampin; Rifamycins; Tuberculosis, Pulmonary | 1985 |
1 other study(ies) available for 3-formylrifamycin sv and isoniazid
| Article | Year |
|---|---|
Stability of rifampicin in dissolution medium in presence of isoniazid.
Topics: Antitubercular Agents; Chromatography, Thin Layer; Drug Compounding; Drug Stability; Hydrochloric Acid; Hydrogen-Ion Concentration; Isoniazid; Regression Analysis; Reproducibility of Results; Rifampin; Rifamycins; Sensitivity and Specificity; Solubility; Spectrophotometry, Ultraviolet | 1999 |